Business Description
Pharma Resources (Shanghai) Co Ltd
ISIN : CNE1000065Q9
Share Class Description:
SZSE:301230: Class ACompare
Compare
Traded in other countries / regions
301230.China IPO Date
2022-11-01Description
Pharma Resources (Shanghai) Co Ltd is engaged in the drug discovery, research and development of pharmaceutical processes, and commercial production of API intermediates.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.92 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | 49.78 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 8.88 | |||||
| Beneish M-Score | -1.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.5 | |||||
| 3-Year EBITDA Growth Rate | -5.7 | |||||
| 3-Year EPS without NRI Growth Rate | -24.6 | |||||
| 3-Year Book Growth Rate | 47.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.1 | |||||
| 9-Day RSI | 60.66 | |||||
| 14-Day RSI | 59.01 | |||||
| 6-1 Month Momentum % | 13.51 | |||||
| 12-1 Month Momentum % | -1.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.12 | |||||
| Quick Ratio | 3.6 | |||||
| Cash Ratio | 2.41 | |||||
| Days Inventory | 64.71 | |||||
| Days Sales Outstanding | 69.88 | |||||
| Days Payable | 88.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.5 | |||||
| Dividend Payout Ratio | 13.2 | |||||
| Forward Dividend Yield % | 1.5 | |||||
| 5-Year Yield-on-Cost % | 1.5 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 0.13 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 22.79 | |||||
| Operating Margin % | -0.49 | |||||
| Net Margin % | 1.35 | |||||
| FCF Margin % | -24.64 | |||||
| ROE % | 0.64 | |||||
| ROA % | 0.48 | |||||
| ROIC % | 0.37 | |||||
| ROC (Joel Greenblatt) % | 0.68 | |||||
| ROCE % | 0.3 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 551.96 | |||||
| Forward PE Ratio | 33.87 | |||||
| PE Ratio without NRI | 1126 | |||||
| PEG Ratio | 53.88 | |||||
| PS Ratio | 7.68 | |||||
| PB Ratio | 3.76 | |||||
| Price-to-Tangible-Book | 3.79 | |||||
| EV-to-EBIT | 1005.46 | |||||
| EV-to-EBITDA | 1005.46 | |||||
| EV-to-Revenue | 7.43 | |||||
| EV-to-FCF | -30.38 | |||||
| Price-to-Peter-Lynch-Fair-Value | 6.47 | |||||
| Price-to-Graham-Number | 13.8 | |||||
| Price-to-Net-Current-Asset-Value | 12.8 | |||||
| Price-to-Net-Cash | 80.43 | |||||
| Earnings Yield (Greenblatt) % | 0.1 | |||||
| FCF Yield % | -3.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharma Resources (Shanghai) Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 513.908 | ||
| EPS (TTM) (Â¥) | 0.051 | ||
| Beta | 0 | ||
| Volatility % | 64.62 | ||
| 14-Day RSI | 59.01 | ||
| 14-Day ATR (Â¥) | 1.647799 | ||
| 20-Day SMA (Â¥) | 27.1905 | ||
| 12-1 Month Momentum % | -1.19 | ||
| 52-Week Range (Â¥) | 16.276923 - 42.3 | ||
| Shares Outstanding (Mil) | 139.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharma Resources (Shanghai) Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharma Resources (Shanghai) Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharma Resources (Shanghai) Co Ltd Frequently Asked Questions
What is Pharma Resources (Shanghai) Co Ltd(SZSE:301230)'s stock price today?
The current price of SZSE:301230 is ¥28.15. The 52 week high of SZSE:301230 is ¥42.30 and 52 week low is ¥16.28.
When is next earnings date of Pharma Resources (Shanghai) Co Ltd(SZSE:301230)?
The next earnings date of Pharma Resources (Shanghai) Co Ltd(SZSE:301230) is .
Does Pharma Resources (Shanghai) Co Ltd(SZSE:301230) pay dividends? If so, how much?
The Dividend Yield %  of Pharma Resources (Shanghai) Co Ltd(SZSE:301230) is 1.5% (As of Today), Highest Dividend Payout Ratio of Pharma Resources (Shanghai) Co Ltd(SZSE:301230) was 13.2. The lowest was 1.85. And the median was 1.85. The  Forward Dividend Yield % of Pharma Resources (Shanghai) Co Ltd(SZSE:301230) is 1.5%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers